Fundraising Fox

Affinia Therapeutics

Waltham, US · Founded 2019 · Delaware corporation · 8 known investors

affiniatx.com ↗

Affinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions. The company uses AI and structural modeling to redesign viral delivery vectors for one-time-dose genetic medicines across rare and prevalent diseases.

AI & Machine LearningBiotechDeep Techin /affinia-therapeutics

Founders & leadership

CF
Carole FaigDirector
RD
Rami DaoudExecutive Officer
DB
Diana BrainardDirector
RM
Rick ModiExecutive Officer, Director
LV
Luc VandenbergheDirector
ES
Elliott SigalDirector
SN
Sean NolanDirector
LR
Laura RichmanExecutive Officer
PK
Petra KaufmannExecutive Officer
RA
Robert AboudExecutive Officer
PC
Paula CobbExecutive Officer
CS
Caroline StoutDirector

Investors · 8

Atlas VentureCambridge · $500K – $1M
EcoR1 CapitalSan Francisco
Eight Roads VenturesBangalore · $5M – $30M
F-Prime Capital PartnersCambridge · $3M – $10Mvia Robert Weisskoff · board
GV (Google Ventures)Mountain View · $250K – $50M
TCG CrossoverPalo Alto
NEA SecondaryreportedTimonium
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40M

Reported raises · per SEC filings

Form D private placements
▶$13.3MraisedOct 2025 · 20 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Carole FaigDirector
  • Rami DaoudExecutive Officer
  • Robert WeisskoffDirector
  • Diana BrainardDirector
  • Rick ModiExecutive Officer, Director
  • David GrayzelDirector
  • Luc VandenbergheDirector
  • Elliott SigalDirector
  • Edward MathersDirector
  • Sean NolanDirector
Offering amount
$45M
Amount sold
$13.3M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$110MraisedMay 2021 · 22 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura RichmanExecutive Officer
  • Rick ModiExecutive Officer, Director
  • Petra KaufmannExecutive Officer
  • Robert AboudExecutive Officer
  • Paula CobbExecutive Officer
  • Edward MathersDirector
  • Sean NolanDirector
  • Caroline StoutDirector
  • Elliot SigalDirector
  • Rob MayExecutive Officer
  • Charles AlbrightExecutive Officer
  • Luc VandenbergheDirector
  • Robert WeisskoffDirector
  • David GrayzelDirector
Offering amount
$110M
Amount sold
$110M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.5MraisedMar 2020 · 16 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert AboudExecutive Officer
  • Robert JohnsonExecutive Officer
  • Sean NolanDirector
  • Luc VandenbergheDirector
  • Rick ModiExecutive Officer, Director
  • David GrayzelDirector
  • Robert WeisskoffDirector
  • Edward MathersDirector
Offering amount
$68.5M
Amount sold
$38.5M
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.3MraisedNov 2019 · 14 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Luk VandenbergheDirector
  • Rick ModiExecutive Officer
Offering amount
$8.3M
Amount sold
$8.3M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news